Menu

drug pricing reform Archive

Don’t Copy European Drug Pricing Policies that Reduced R&D Innovation

TweetShareSharePin0 Shares U.S. companies succeed and maintain their success by engaging in research & development (R&D) that results in innovative products and services reaching customers around the world. But U.S. policies that create tax or regulatory penalties, such as the drug pricing and excise tax proposal lawmakers are considering in the reconciliation package, can curtail
You cannot copy content of this page
Social Media Auto Publish Powered By : XYZScripts.com